The presence and outcome effect of white coat hypertension in pregnancy was determined with 24-h ambulatory blood pressure (BP) monitoring. Sixty women presenting with high clinic BP (у140/90 mm Hg) in the second trimester were included. Patients were divided into two groups based on daytime ambulatory BP findings: Ͻ135/85 mm Hg, white coat hypertension (n = 37); у135/85 mm Hg, 'true' hypertension (n = 23). Complicated pregnancy outcome was defined as the presence of pre-eclampsia and/or intrauterine growth restriction. Groups were compared for pregnancy outcome and for background and delivery factors. The predictive value of ambulatory BP measurements for pregnancy outcome was determined.
Introduction
Hypertensive disorders of pregnancy are an important cause of maternal death and contribute to perinatal mortality and morbidity. 1, 2 The early diagnosis of pre-eclampsia and of pre-eclampsia complicated by intrauterine growth restriction (IUGR) remains one of the important aims of antenatal care. Nevertheless, despite the many potential screening tests available, none has been shown to be of clinical significance. 3, 4 Though some studies have suggested that the appearance of hypertension in the second trimester may be predictive of pre-eclampsia, 5, 6 it is often difficult to detect small changes in blood pressure (BP) in routine clinical practice, 5 and these small changes may have poor individual predictive value for disease. 7 The introduction of non-invasive ambulatory BP monitoring (ABPM) has enabled clinicians to measure BP over longer periods of time and across a wider variety of circumstances than with clinical measurements. Use of this technique has revealed a subgroup of patients who have persistently high clinic BP but a normal ambulatory or self-measured BP. This phenomenon has been termed 'white coat hypertension' (WCH), 8, 9 in light of findings that BP Pregnancy outcome was better in the white coat hypertension group than in the true hypertension group: pre-eclampsia-3 (8.1%) vs 13 (56.5%) (P = 0.0046); intrauterine growth restriction-5 (13.5%) vs 10 (43.4%) (P = 0.0139); and preterm delivery-11 (29.7%) vs 15 (65.2%) (P = 0.015). Night-time ambulatory BP measurements were the best predictor of complicated pregnancy, followed by daytime and 24-h measurements.
We conclude that second trimester ambulatory BP monitoring can be used to differentiate patients who have white coat hypertension, which is associated with a better pregnancy outcome than true hypertension. measurement in the clinic by a physician can, by itself, trigger a pressor response.
There is not much information on the role of WCH in pregnancy or its effect on pregnancy outcome. The aim of this study was to use ABPM in women with a high clinic BP in the second trimester in order to determine the presence of WCH in this subgroup and its effect on pregnancy outcome compared with 'true' hypertension.
Patients and methods
The study population consisted of pregnant women at 14 to 28 weeks of gestation who were referred from community clinics to the Hypertension in Pregnancy Clinic from January 1994 to December 1997 because of high BP. None had a definite diagnosis of chronic hypertension or chronic renal disease, and all were untreated before the clinic visit.
On admission, BP was measured by an experienced nurse using a standard mercury sphygmomanometer. Arm circumference was measured and a cuff with a larger bladder was used for arms larger than 32 cm. The recorded value was the mean of three measurements made in the right arm with the subject in a seated position after being supine for 10 min. The fifth Korotkoff sound was used as the diastolic BP. Clinic hypertension was defined as a BP of 140/90 mm Hg or more after at least two readings 30 min apart performed by the same nurse. All women with clinic hypertension (n = 60) were assigned to the study and subjected to 24-h ABPM. Women with normal clinic BP levels were excluded. Laboratory evaluations of liver, renal, haematological and coagulation parameters were done routinely, and subjects with evidence suggesting preeclampsia, such as severe hypertension (160/110 mm Hg or more), proteinuria (у300 mg per day) or other laboratory abnormalities, were also excluded from the study.
ABPM was performed with a Spacelabs model 90202 monitor (Spacelabs Inc, WA, USA). This is an earlier version of the Spacelabs model 90207 which has been validated for use in pregnancy. 10 After the subjects had adjusted to the monitor, they were instructed to continue normal activity during ABPM but to stop activity while the device was taking measurements. ABPM was performed on the nondominant arm to minimise interference with daily activity. Readings of systolic and diastolic BP and heart rate were taken every 30 min during ambulation (when the patient was awake) and during sleep; for purposes of analysis, daytime was defined as 07.00 to 22.59 and night-time as 23.00 to 06.59.
11
Mean 24-h daytime and night-time systolic and diastolic BP and heart rate were calculated from the BP and heart rate patterns observed in each subject. The data were downloaded to an IBM-compatible computer for analysis. Records containing less than 20 valid readings during ambulatory periods and less than eight valid readings during sleep periods were eliminated from the analysis.
Group allocation was performed according to the European 12 and American 13 standard of ambulatory daytime arterial BP for the non-pregnant population. 11 Subjects with an ambulatory daytime pressure of Ͻ135/85 mm Hg were assigned to the WCH group, and those with a value of у135/85 mm Hg were assigned to the true hypertension (TH) group. Subjects were also divided into WCH and TH groups according to normal reference values for normal pregnancy for ambulatory BP.
14 A cut-off of +2 standard deviations from the mean was used: mean 24-h BP у127/75 mm Hg, mean daytime BP у134/82 mm Hg and mean night-time BP у117/67 mm Hg. Complicated pregnancy outcome was defined as the presence of pre-clampsia (increase in diastolic BP by at least 25 mm Hg from the reading in the first half of pregnancy, with a maximum value greater than 90 mm Hg, 15 as well as proteinuria of more than 300 mg in a 24-h urine collection) and/or IUGR (birth weight below the 10th percentile of the growth curve). The groups were compared for demographic and biologic characteristics (age, nulliparity) and also for outcome measurements (occurrence of pre-eclampsia and IUGR, gestational week of delivery, incidence of preterm delivery (Ͻ37 weeks), birth weight, and mode of delivery). The ABPM results were blinded to the prenatal care clinicians to prevent the introduction of a bias in the diagnosis of pregnancy complications or in the interventions offered.
Clinical data are given as mean and standard error of the mean (s.e.m.), and frequencies are given in percentage. Student's t-test was used for betweengroup comparison of all normally distributed variables of birth weight and gestational age at delivery. Chi-square test was used for evaluating frequencies. To predict complicated pregnancy outcome by clinic BP or by daytime, night-time and 24-h ABPM measurements, stepwise logistic regression models were fitted to the data; P values less than 0.05 were considered significant.
Results
Sixty patients were found to be eligible for the study. Thirty-seven were allocated to the WCH group and 23 to the TH group. The demographic and biological characteristics of the study groups are presented in Table 1 . No significant differences were observed in mean maternal age, percent of nulliparity, and mean gestational week at admission; nor was there a difference in mean weight, mean height and race. Mean office BP and 24-h ABPM values are shown in Table 2 . No significant differences were detected in mean clinic BP values (149/94 mm Hg for WCH and 148/98 mm Hg for TH). Although the white coat effect was defined according to daytime ABPM (cutoff 135/85 mm Hg), 24-h and night-time ABPM were also significantly lower in the WCH group than in the TH group. No significant difference was observed in heart rate. Table 3 shows the findings for pregnancy outcome. Results were better in the WCH than in the TH group. Pre-eclampsia was diagnosed in 13 TH patients (56.5%) but in only three WCH patients (8.1%) (P = 0.0046); IUGR in 10 TH patients (43.4%) but in only five WCH patients (13.5%) (P = 0.0139); and preterm delivery in 15 (65.2%) TH patients and 11 (29.7%) WCH patients (P = 0.015). Mean birth weight was significantly higher in the WCH group (3143 g) than that in the TH group (2508 g) (P Ͼ 0.0098), but there was no difference in gestational age at delivery or rate of cesarean section. Using a logistic regression model, the probability of complicated pregnancy outcome (occurrence of preeclampsia and/or IUGR) was calculated with the following formula: where P is the probability of complicated pregnancy outcome and BP is the mean BP in mm Hg. Analysis of the various BP measurements in the second trimester yielded night-time ABPM as the most significant predictive parameter for complicated pregnancy outcome (odds ratio 1.1 for an increase in 1 mm Hg; Cl (95%) 1.03 − 1.18; P = 0.0008), slightly better than daytime ABPM (odds ratio 1.1; Cl 1.02 − 1.18; P = 0.0035) and 24-h ABPM (P = 0.0026). Mean clinic BP did not significantly predict complicated pregnancy outcome. The use of a different cut-off point for the definition of WCH based on the results for ABPM in normal pregnant women 14 yielded slightly different results for pregnancy outcome. When a value of у134/82 mm Hg for mean daytime ABPM was used, pre-eclampsia was diagnosed in 14 out of 28 subjects (50%) allocated to the TH group but in only two out of 32 (6.2%) in the WCH group (P = 0.02). With a cut-off of у127/75 mm Hg for mean 24-h ABPM, pre-eclampsia was diagnosed in 11 out of 25 TH patients (44%) compared to five out of 35 WCH patients (14%) (P = 0.06). With a cut-off point of у117/67 mm Hg for night-time ABPM, pre-eclampsia was diagnosed in 10 out of 27 TH patients (37%) and in six out of 37 WCH patients (16%) (P = 0.06).
Discussion
The present study demonstrates that pregnant women with high second trimester clinic BP who are diagnosed as having WCH by ABPM have a better pregnancy outcome in terms of occurrence of pre-eclampsia and IUGR than those with 'true' hypertension. These results describe our experience in clinical practice with a more refined method of identifying a high-risk subgroup of pregnant women, namely those with previously undiagnosed true hypertension. Little attention had been given in the literature to white coat effect until 1983, when Mancia et al 8 identified it as a distinct entity. A wide ranging prevalence of WCH has been reported in the nonpregnant population, from 7% to 54%, probably owing to the different nature of the populations studied and the different diagnostic criteria used in the various studies. 12 Moreover, the significance and prognostic implications of WCH remain controversial. Some investigators claim that WCH patients have a better prognosis and less cardiovascular morbidity than true hypertensives, but a worse prognosis than control subjects. 16 It has also been demonstrated that target organ damage, especially left ventricular hypertrophy, is more closely correlated with ambulatory than with clinic BP. 16, 17 The information on the difference between clinic and ambulatory BP in pregnancy is controversial, and on WCH in pregnancy, minimal. According to different studies, clinic BP is higher, 18 equal to, 19 and lower 20 than awake ambulatory BP. These discrepancies may reflect the different methods of determining clinic BP (by a clinician vs a member of the research team under more relaxed conditions), device error or different levels of daily activity.
Therefore, for the present study, we used the generally accepted definition of WCH: persistently elevated clinic BP of у140/90 mm Hg and normal daytime ambulatory BP of Ͻ135/85 mm Hg. [11] [12] [13] Using ABPM, we found that about 62% of the women referred to our clinic for high second trimester BP actually had WCH. We cannot rule out the possibility that the pregnant patients with hypertension recruited to this study before 20 weeks' gestation may have had undiagnosed chronic hypertension or chronic renal disease. However, another study has also detected a similar incidence of WCH (62%) with ABPM in 120 subjects at 28 to 37 weeks of pregnancy. 21 We identified the true hypertensives by the higher occurrence of pre-eclampsia and IUGR. This method allows us to concentrate on the specific patients who require a special management regimen. A better and earlier identification of the WCH subgroup may reduce unnecessary admissions and interventions in obstetric care. However, we must not fail to consider that although outcome was generally better in the WCH group, there were still relatively high incidences of pre-eclampsia, IUGR, preterm delivery and cesarean deliveries.
We are aware that our definition of WCH was based on standards set in the non-pregnant population. Several studies have set normal reference values for ABPM in pregnancy, 14, 18, 19, 22 others have defined WCH in pregnancy as a mean 24-h diastolic BP of 85 mm Hg, 21 as we did, or as at least a 5 mm Hg difference in diastolic or systolic readings in the averaged ABPM from the readings obtained in the clinic. 23 Interestingly, Churchill and Beevers 14 who used the Spacelabs 90207 in a cohort of normal pregnant women at a similar gestational week to ours noted similar values to the cut-off points in our study. Using Churchill's mean ± 2 s.d. values (134/82 mm Hg for mean daytime ABPM vs 135/85 mm Hg in our study), we observed similar differences in pregnancy outcome between the TH and WCH patients. Therefore, we suggest that it is preferable to use an ABPM model that analyses continuous measurements rather than numerous cut-off points. By logistic regression model, we found that the best predictor of pre-eclampsia and IUGR was nighttime ambulatory BP, followed by daytime and 24 h BP. This model enables the analysis of the association of continuous increases in 1 mm Hg in BP with an increase in risk. The results are in agreement with other investigators who used ABPM at different cutoff points to predict pre-eclampsia [24] [25] [26] and foetal growth. 27 Our findings and other recent data support the assumption that ambulatory BP readings in pregnant women should be considered completely different entities from office BP readings, 14 and that there is probably an inverse linear relationship between (ambulatory) BP and pregnancy outcome. 24, 25 In conclusion, the use of second-trimester ABPM in women with high clinic BP values can enable clinicians to define the subgroup that has WCH, which is associated with a better pregnancy outcome than true hypertension. However, WCH in pregnancy is not a benign condition. These women should be assiduously followed because of the higher incidence of complications such as preeclampsia, IUGR and preterm delivery than would normally be expected in a normal population. It may, however, be possible to manage this group in a less interventional manner. This needs to be confirmed in a larger scale, randomised controlled trial.
